Reproductive Health addresses the reproductive processes, functions and system at all stages of life.
Ferring Pharmaceuticals is committed to the research and development of products to address infertility, women’s obstetrics needs and gynecological disorders.
Through its portfolio of innovative products, Ferring’s goal is to provide the best treatments to support every stage of the reproductive cycle.
Ferring is a leader in the treatment of infertility and its products have proven to have an excellent track record over the years. Ferring’s research division continues to explore new and exciting solutions aimed at addressing infertility problems.
Up to 25 % of all couples may experience problems in conceiving a child, a figure that appears to be rising, partly due to the trend to delay pregnancy until an older age. The World Health Organization estimates that there are about 60 to 80 million cases of infertility around the world.
Treatment of infertility is one of Ferring’s key areas of expertise and we are firmly committed to progress in the field of Assisted Reproductive Technology (ART).
Obstetrics focuses on the care of women during pregnancy, until labor and birth. Most pregnancies proceed to full term without any complications. When additional help is needed, Ferring’s obstetrics portfolio is focused on providing therapeutic options and products with established safety and efficacy profiles.
Ferring’s portfolio includes products that:
- Delay imminent premature birth
- Prevent postpartum hemorrhage
- Help delayed labor through labor induction
Ferring is one of the leaders in obstetric care and continues to investigate new therapies to help reduce the number of infants that are born prematurely.
Gynecology deals with disorders of the female reproductive system.
Ferring offers a therapeutic treatment to help women with heavy monthly menstrual bleeding.
Ferring is interested in developing novel products in the gynecological field that address important indications, where there is a clear unmet medical need, such as;